Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2017 (2017), Article ID 8409829, 7 pages
https://doi.org/10.1155/2017/8409829
Research Article

Malignancy in Membranous Nephropathy: Evaluation of Incidence

1Department of Nephrology, Auckland City Hospital, 2 Park Drive, Grafton, Auckland 1023, New Zealand
2Department of Pathology, Auckland City Hospital, 2 Park Drive, Grafton, Auckland 1023, New Zealand

Correspondence should be addressed to Basil Alnasrallah

Received 28 February 2017; Revised 15 May 2017; Accepted 7 June 2017; Published 16 July 2017

Academic Editor: Anil K. Agarwal

Copyright © 2017 Basil Alnasrallah et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Ponticelli and R. J. Glassock, “Glomerular diseases: membranous nephropathy-a modern view,” Clinical Journal of the American Society of Nephrology, vol. 9, no. 3, pp. 609–616, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. W. L. Lai, T. H. Yeh, P. M. Chen et al., “Membranous nephropathy: a review on the pathogenesis, diagnosis, and treatment,” Journal of the Formosan Medical Association, vol. 114, no. 2, pp. 102–111, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Haas, S. M. Meehan, T. G. Karrison, and B. H. Spargo, “Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976–1979 and 1995–1997,” American Journal of Kidney Diseases, vol. 30, no. 5, pp. 621–631, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. G. L. Braden, J. G. Mulhern, M. H. O'Shea, S. V. Nash, A. A. Ucci Jr., and M. J. Germain, “Changing incidence of glomerular diseases in adults,” American Journal of Kidney Diseases, vol. 35, no. 5, pp. 878–883, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. R. J. Glassock, “Diagnosis and natural course of membranous nephropathy,” Seminars in Nephrology, vol. 23, no. 4, pp. 324–332, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. A. G. Wasserstein, “Membranous glomerulonephritis,” Journal of the American Society of Nephrology, vol. 8, no. 4, pp. 664–674, Apr 1997. View at Google Scholar
  7. J. C. Lee, H. Yamauchi, and J. Hopper Jr., “The association of cancer and the nephrotic syndrome.,” Annals of Internal Medicine, vol. 64, no. 1, pp. 41–51, 1966. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Leeaphorn, P. Kue-A-Pai, N. Thamcharoen, P. Ungprasert, M. B. Stokes, and E. L. Knight, “Prevalence of cancer in membranous nephropathy: A systematic review and meta-analysis of observational studies,” American Journal of Nephrology, vol. 40, no. 1, pp. 29–35, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Bjørneklett, B. E. Vikse, E. Svarstad et al., “Long-Term Risk of Cancer in Membranous Nephropathy Patients,” American Journal of Kidney Diseases, vol. 50, no. 3, pp. 396–403, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Lefaucheur, B. Stengel, and D. Nochy, “Membranous nephropathy and cancer: epidemiologic evidence and determinants of high-risk cancer association,” Kidney International, vol. 70, no. 8, pp. 1510–1517, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. S. A. Birkeland and H. H. Storm, “Glomerulonephritis and malignancy: a population-based analysis,” Kidney International, vol. 63, no. 2, pp. 716–721, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Bacchetta, L. Juillard, P. Cochat, and J.-P. Droz, “Paraneoplastic glomerular diseases and malignancies,” Critical Reviews in Oncology/Hematology, vol. 70, no. 1, pp. 39–58, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. P. M. Ronco, “Paraneoplastic glomerulopathies: new insights into an old entity,” Kidney International, vol. 56, no. 1, pp. 355–377, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Eknoyan, N. Lameire, K.-U. Eckardt et al., “Kidney disease: improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis,” Kidney International Supplements, vol. 2, pp. 139–274, 2012. View at Google Scholar
  15. H. Ohtani, H. Wakui, A. Komatsuda et al., “Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy,” Nephrology Dialysis Transplantation, vol. 19, no. 3, pp. 574–579, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. Z. Qu, G. Liu, J. Li et al., “Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy,” Nephrology Dialysis Transplantation, vol. 27, no. 5, pp. 1931–1937, 2012. View at Publisher · View at Google Scholar
  17. J. Lönnbro-Widgren, K. Ebefors, J. Mölne, J. Nyström, and B. Haraldsson, “Glomerular IgG subclasses in idiopathic and malignancy-associated membranous nephropathy,” Clinical Kidney Journal, vol. 8, no. 4, pp. 433–439, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Murtas and G. M. Ghiggeri, “Membranous glomerulonephritis: histological and serological features to differentiate cancer-related and non-related forms,” Journal of Nephrology, vol. 29, no. 4, pp. 469–478, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. J. A. J. G. van den Brand, P. R. van Dijk, J. M. Hofstra, and J. F. M. Wetzels, “Cancer risk after cyclophosphamide treatment in idiopathic membranous nephropathy,” Clinical Journal of the American Society of Nephrology, vol. 9, no. 6, pp. 1066–1073, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Faurschou, I. J. Sorensen, L. Mellemkjaer et al., “Malignancies in wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients,” Journal of Rheumatology, vol. 35, no. 1, pp. 100–105, 2008. View at Google Scholar · View at Scopus
  21. S. Bernatsky, R. Ramsey-Goldman, L. Joseph et al., “Lymphoma risk in systemic lupus: effects of disease activity versus treatment,” Annals of the Rheumatic Diseases, vol. 73, no. 1, pp. 138–142, 2014. View at Google Scholar
  22. A. Pani, C. Porta, L. Cosmai et al., “Glomerular diseases and cancer: evaluation of underlying malignancy,” Journal of Nephrology, vol. 29, no. 2, pp. 143–152, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. J. F. Cambier and P. Ronco, “Onco-nephrology: glomerular diseases with cancer,” Clinical Journal of the American Society of Nephrology, vol. 7, no. 10, pp. 1701–1712, 2012. View at Google Scholar
  24. L. H. Beck Jr., “Membranous nephropathy and malignancy,” Seminars in Nephrology, vol. 30, no. 6, pp. 635–644, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Mannik, S. A. Stapleton, M. W. Burns, C. E. Alpers, and V. J. Gauthier, “Glomerular subendothelial and subepithelial immune complexes, containing the same antigen, are removed at different rates,” Clinical & Experimental Immunology, vol. 84, no. 2, pp. 367–372, 1991. View at Publisher · View at Google Scholar · View at Scopus